Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries.
dc.contributor.author | Velpandian, T | en_US |
dc.contributor.author | Sharma, C | en_US |
dc.contributor.author | Garg, S P | en_US |
dc.contributor.author | Mandal, S | en_US |
dc.contributor.author | Ghose, S | en_US |
dc.date.accessioned | 2007-11-24 | en_US |
dc.date.accessioned | 2009-05-29T08:49:29Z | |
dc.date.available | 2007-11-24 | en_US |
dc.date.available | 2009-05-29T08:49:29Z | |
dc.date.issued | 2007-11-24 | en_US |
dc.identifier.citation | Velpandian T, Sharma C, Garg SP, Mandal S, Ghose S. Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries. Indian Journal of Ophthalmology. 2007 Nov-Dec; 55(6): 488-90 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/70911 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.ijo.in | en_US |
dc.source.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635973/ | en_US |
dc.subject.mesh | Angiogenesis Inhibitors --economics | en_US |
dc.subject.mesh | Antibodies, Monoclonal --administration & dosage | en_US |
dc.subject.mesh | Cost-Benefit Analysis | en_US |
dc.subject.mesh | Developing Countries | en_US |
dc.subject.mesh | Dose-Response Relationship, Drug | en_US |
dc.subject.mesh | Drug Dosage Calculations | en_US |
dc.subject.mesh | Drug Packaging --economics | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Retinal Diseases --drug therapy | en_US |
dc.title | Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries. | en_US |
dc.type | Letter | en_US |
Files
License bundle
1 - 1 of 1